PL1988971T3 - Kompozycje i sposoby zachowywania funkcji mózgu - Google Patents

Kompozycje i sposoby zachowywania funkcji mózgu

Info

Publication number
PL1988971T3
PL1988971T3 PL06845640T PL06845640T PL1988971T3 PL 1988971 T3 PL1988971 T3 PL 1988971T3 PL 06845640 T PL06845640 T PL 06845640T PL 06845640 T PL06845640 T PL 06845640T PL 1988971 T3 PL1988971 T3 PL 1988971T3
Authority
PL
Poland
Prior art keywords
compositions
methods
brain function
preserving brain
preserving
Prior art date
Application number
PL06845640T
Other languages
English (en)
Inventor
Brian T. Larson
Samuel T. Henderson
Matthew A. Roberts
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL1988971T3 publication Critical patent/PL1988971T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06845640T 2005-12-15 2006-12-15 Kompozycje i sposoby zachowywania funkcji mózgu PL1988971T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75139105P 2005-12-15 2005-12-15
EP06845640.9A EP1988971B1 (en) 2005-12-15 2006-12-15 Compositions and methods for preserving brain function
PCT/US2006/048077 WO2007070701A2 (en) 2005-12-15 2006-12-15 Compositions and methods for preserving brain function

Publications (1)

Publication Number Publication Date
PL1988971T3 true PL1988971T3 (pl) 2018-08-31

Family

ID=38163558

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06845640T PL1988971T3 (pl) 2005-12-15 2006-12-15 Kompozycje i sposoby zachowywania funkcji mózgu

Country Status (16)

Country Link
US (1) US20100144875A1 (pl)
EP (1) EP1988971B1 (pl)
JP (1) JP5537809B2 (pl)
CN (1) CN101405054B (pl)
AU (1) AU2006326040B2 (pl)
BR (1) BRPI0619905A2 (pl)
CA (1) CA2632550C (pl)
ES (1) ES2665744T3 (pl)
HU (1) HUE037129T2 (pl)
MX (1) MX2008007517A (pl)
NZ (1) NZ569235A (pl)
PL (1) PL1988971T3 (pl)
RU (1) RU2437656C2 (pl)
TR (1) TR201807470T4 (pl)
WO (1) WO2007070701A2 (pl)
ZA (1) ZA200806111B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ES2323940T3 (es) 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
EP2500017B1 (en) * 2006-04-03 2017-09-06 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
PT2650380E (pt) 2007-07-31 2016-01-14 Accera Inc Utilização de testagem genómica e compostos cetogénicos para o tratamento de função cognitiva reduzida
ES2664777T5 (es) 2007-10-04 2021-10-25 Nestle Sa Composiciones y procedimientos para mejorar la función cognitiva
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
CA2729622C (en) 2008-07-03 2017-07-25 Accera, Inc. Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders
MX2011000652A (es) * 2008-07-18 2011-06-16 Dart Neuroscience Llc Metodos y sistemas para evaluar agentes para la memoria.
EP2464350B1 (en) 2009-09-11 2016-08-24 Nestec S.A. Compositions and methods for enhancing cognitive and related functions in animals
JP5860803B2 (ja) * 2010-03-18 2016-02-16 日清オイリオグループ株式会社 生体内の蛋白質の分解抑制剤
US20150238441A1 (en) * 2012-10-05 2015-08-27 University Of Rochester Modulation of Branched Amino Acid Concentrations to Treat Metabolic Diseases
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
CN104837358B (zh) 2012-12-14 2019-03-29 希尔氏宠物营养品公司 用于陪伴动物的抗衰老食物
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
KR101791622B1 (ko) * 2014-07-17 2017-10-30 닛신 오일리오그룹 가부시키가이샤 곡분을 실질적으로 포함하지 않는 구운 과자
EP3173089B1 (en) * 2014-07-23 2023-10-25 The Food Science Institute Foundation Agent for improving brain function and agent for preventing cognitive impairment
RU2017114438A (ru) * 2014-10-10 2018-10-26 Нестек Са Композиции и способы повышения подвижности или активности или лечения дряхлости
CN108348496A (zh) * 2015-12-04 2018-07-31 雀巢产品技术援助有限公司 中链三甘油酯组合物
CA3004996A1 (en) * 2015-12-04 2017-06-08 Nestec S.A. Method for improving cognition
WO2017199223A1 (en) * 2016-05-20 2017-11-23 Nestec Sa Nutritional compositions for cardciac protection in companion animals
EP3463321A1 (en) * 2016-05-27 2019-04-10 Nestec S.A. Nutritional composition for treating or preventing impaired mobility
BR112019019098A2 (pt) 2017-03-15 2020-04-22 Cerecin Inc composições farmacêuticas tendo altos carregamentos de fármaco de triglicerídeos de cadeia média, seu método de produção e seu uso
US20190183832A1 (en) * 2017-12-20 2019-06-20 Michael Guarnieri Nutritional bolus for animals
WO2019234628A1 (en) * 2018-06-07 2019-12-12 Société des Produits Nestlé S.A. Methods and compositions for increasing ketone bodies in animals
CN112312903A (zh) * 2018-07-10 2021-02-02 雀巢产品有限公司 用于增加酮暴露的mct制剂以及制备和使用此类制剂的方法
JP7516376B2 (ja) 2018-12-18 2024-07-16 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 混合トリグリセリド
KR102517992B1 (ko) * 2022-05-26 2023-04-05 주식회사 에이엘 네트웍스 인지장애 및 뇌기능 개선을 위한 펫푸드 조성물 및 이의 제조 방법
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation
CN117115754B (zh) * 2023-10-23 2023-12-26 贵州省种畜禽种质测定中心 基于计算机视觉的鸭舍智能化监测方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
EP0106341B1 (en) * 1982-10-20 1989-01-11 Takeda Chemical Industries, Ltd. Physiologically active substance p-23924, its production and use
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4997976A (en) * 1988-11-15 1991-03-05 Henri Brunengraber Use of 1,3-butanediol acetoacetate in parenteral oral nutrition
US5190863A (en) * 1990-06-29 1993-03-02 Miles Inc. Composition for determining the presence or concentration of D-β-hydroxybutyrate
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
JP3486778B2 (ja) * 1993-04-02 2004-01-13 三菱ウェルファーマ株式会社 アルツハイマー病予防治療剤
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
ES2530753T3 (es) * 1997-03-17 2015-03-05 Btg Int Ltd Composiciones terapéuticas que comprenden cuerpos cetónicos y precursores de los mismos
US6093418A (en) * 1998-09-16 2000-07-25 The Iams Company Method for removing nitrogenous waste products from animals with hepatic disease
ES2323940T3 (es) * 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ATE411077T1 (de) * 2001-01-12 2008-10-15 Waratah Pharmaceuticals Inc Zusammensetzungen, welche gastrin/cck- rezeptorligande und egf-rezeptorligande enthalten,zur induzierung der neogenese von inselzellen
US6835759B2 (en) * 2001-08-28 2004-12-28 Basf Corporation Dual cure coating composition and processes for using the same
DE60238663D1 (de) * 2002-04-05 2011-02-03 Nestle Sa Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
EP1875816A3 (en) * 2003-07-10 2008-03-12 Carl A. Forest Beverages with specialized supplements
MXPA06000693A (es) * 2003-09-05 2006-04-11 Hills Pet Nutrition Inc Composicion para consumo animal.
IL158139A0 (en) * 2003-09-25 2004-09-27 Enzymotec Ltd Stabilized formulations of phosphatidyl serine
US20050070602A1 (en) * 2003-09-30 2005-03-31 Jen-Wei Chiao Method of modulating immune response by administration of immuno-activation agent
EP1915144A4 (en) * 2005-06-20 2009-08-19 Accera Inc METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
RU2008128444A (ru) * 2005-12-12 2010-01-20 Хиллс Пет Ньютришн, Инк. (US) Способ получения показателя влияния на здоровье для композиции кормового продукта
EP2500017B1 (en) * 2006-04-03 2017-09-06 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment

Also Published As

Publication number Publication date
US20100144875A1 (en) 2010-06-10
CA2632550A1 (en) 2007-06-21
CN101405054B (zh) 2013-07-17
HUE037129T2 (hu) 2018-08-28
JP5537809B2 (ja) 2014-07-02
RU2008128859A (ru) 2010-01-20
CA2632550C (en) 2017-07-25
MX2008007517A (es) 2009-03-04
AU2006326040B2 (en) 2012-02-09
TR201807470T4 (tr) 2018-06-21
NZ569235A (en) 2011-12-22
ZA200806111B (en) 2010-09-29
JP2009524587A (ja) 2009-07-02
EP1988971B1 (en) 2018-02-28
BRPI0619905A2 (pt) 2011-10-25
EP1988971A2 (en) 2008-11-12
WO2007070701A3 (en) 2008-11-20
WO2007070701A2 (en) 2007-06-21
ES2665744T3 (es) 2018-04-27
AU2006326040A1 (en) 2007-06-21
CN101405054A (zh) 2009-04-08
RU2437656C2 (ru) 2011-12-27

Similar Documents

Publication Publication Date Title
ZA200806111B (en) Compositions and methods for preserving brain function
IL190259A0 (en) Compositions and methods comprising panax species
EP1895838A4 (en) COMPOSITIONS AND METHODS
GB0522287D0 (en) Method and compositions
IL192098A (en) Preparations and Methods for Manufacturing Preparations
IL186973A0 (en) Compositions and methods for treatment for neoplasms
EP1959929A4 (en) COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
IL189795A0 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
EP1835803A4 (en) COMPOSITION FOR PRESERVING PLATES AND METHOD OF USING SAME
IL211089A0 (en) Compositions and methods for cell killing
GB0525314D0 (en) Method and composition
IL186963A0 (en) Methods and compositions for treating pain
ZA200608932B (en) Method and compositions for epilation
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
EP1843734A4 (en) COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS
EP1962852A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
IL220806A0 (en) Method and compositions for enhancing vascular access
EP1991237A4 (en) CHEMOPROTECTIVE METHODS AND COMPOSITIONS
ZA200803283B (en) Pharmaceutical gallium compositions and methods
ZA200803712B (en) Methods and compositions for improving cognitive function
IL184834A0 (en) Compositions and methods for the manufacture thereof
ZA200608935B (en) Methods and compositions for epilation
GB0524927D0 (en) Compositions and method
ZA200707490B (en) Methods and compositions for modulatiing vascular integrity
ZA200802969B (en) Composition and method